WallStreetZenWallStreetZen

NASDAQ: NAOV
Nanovibronix Inc Stock

$0.99+0.00 (+0%)
Updated Mar 1, 2024
NAOV Price
$0.99
Fair Value Price
N/A
Market Cap
$2.02M
52 Week Low
$0.73
52 Week High
$4.34
P/E
-0.31x
P/B
0.43x
P/S
3.38x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.00M
Earnings
-$4.96M
Gross Margin
49.8%
Operating Margin
-442.43%
Profit Margin
-493.7%
Debt to Equity
0.57
Operating Cash Flow
-$4M
Beta
0.51
Next Earnings
Apr 15, 2024
Ex-Dividend
N/A
Next Dividend
N/A

NAOV Overview

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NAOV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NAOV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NAOV is good value based on its book value relative to its share price (0.43x), compared to the US Medical Devices industry average (4.01x)
P/B vs Industry Valuation
NAOV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NAOV due diligence checks available for Premium users.

Be the first to know about important NAOV news, forecast changes, insider trades & much more!

NAOV News

Valuation

NAOV fair value

Fair Value of NAOV stock based on Discounted Cash Flow (DCF)
Price
$0.99
Fair Value
$1.83
Undervalued by
45.76%
NAOV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NAOV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.31x
Industry
28.97x
Market
36.17x

NAOV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.43x
Industry
4.01x
NAOV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NAOV's financial health

Profit margin

Revenue
$458.0k
Net Income
-$727.0k
Profit Margin
-158.7%
NAOV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NAOV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.4M
Liabilities
$2.7M
Debt to equity
0.57
NAOV's short-term assets ($7.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NAOV's short-term assets ($7.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NAOV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NAOV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$682.0k
Investing
$0.0
Financing
$4.2M
NAOV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NAOV vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
NAOV$2.02M-0.20%-0.31x0.43x
TIVC$2.07M-17.06%-0.03x0.36x
NUWE$1.93M-0.51%0.02x0.25x
RSLS$2.29M+3.57%-0.00x0.74x
DYNT$2.38M0.00%-0.35x0.15x

Nanovibronix Stock FAQ

What is Nanovibronix's quote symbol?

(NASDAQ: NAOV) Nanovibronix trades on the NASDAQ under the ticker symbol NAOV. Nanovibronix stock quotes can also be displayed as NASDAQ: NAOV.

If you're new to stock investing, here's how to buy Nanovibronix stock.

What is the 52 week high and low for Nanovibronix (NASDAQ: NAOV)?

(NASDAQ: NAOV) Nanovibronix's 52-week high was $4.34, and its 52-week low was $0.73. It is currently -77.24% from its 52-week high and 36.28% from its 52-week low.

How much is Nanovibronix stock worth today?

(NASDAQ: NAOV) Nanovibronix currently has 2,046,308 outstanding shares. With Nanovibronix stock trading at $0.99 per share, the total value of Nanovibronix stock (market capitalization) is $2.02M.

Nanovibronix stock was originally listed at a price of $70.00 in May 28, 2015. If you had invested in Nanovibronix stock at $70.00, your return over the last 8 years would have been -98.59%, for an annualized return of -41.29% (not including any dividends or dividend reinvestments).

How much is Nanovibronix's stock price per share?

(NASDAQ: NAOV) Nanovibronix stock price per share is $0.99 today (as of Mar 1, 2024).

What is Nanovibronix's Market Cap?

(NASDAQ: NAOV) Nanovibronix's market cap is $2.02M, as of Mar 5, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nanovibronix's market cap is calculated by multiplying NAOV's current stock price of $0.99 by NAOV's total outstanding shares of 2,046,308.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.